Miracle

Name: Miracle
Brand: Miracle

AI Native

Accelerate Clinical Trials with Automated Insights. Goodbye Spreadsheet Chaos, Hello Transparency & Oversight.

Est 2023|Raised $500K

LinkedIn 2K|Website|FTEs 67|HQ San Francisco, California, US

01Competitive Landscape

Narrative analysis

Areas where Miracle appears to align with buyer needs: - As an overlay dashboard, the product is positioned to provide visibility for teams that use multiple vendors and require consolidated operational reporting. - It may be a faster path to operational visibility than attempting to replace core systems mid-study. Areas where competitors may have advantages: - Medidata and Veeva provide deeper end-to-end workflows (EDC, CTMS/eTMF, payments, etc.) and established enterprise governance. - Vendors focused on analytics or broader platforms (e.g., Saama) emphasize machine learning and automation at scale, which may be preferred by larger enterprises seeking advanced automation. Sources: Official vendor product pages and broader industry coverage.

	Miracle (vendor product site)	Medidata (Rave / Clinical Cloud)	Veeva Vault EDC
Starting Price	Not publicly disclosed (tiered packaging only)	Not publicly disclosed; site-based pricing model described	Not publicly disclosed (contact sales)
Best For	Organizations seeking a dashboard/oversight layer that aggregates data across disparate systems	Sponsors/CROs seeking a broad, integrated clinical platform suite (EDC + adjacent modules)	Sponsors seeking an EDC integrated with Veeva’s broader clinical ecosystem
Key Strength	Positioned as an overlay dashboard providing visibility across disparate systems; focus on consolidating operational metrics and reporting	Mature enterprise platform breadth; widely used EDC ecosystem and integrations	Enterprise adoption and ecosystem integration with other Veeva products
Key Weakness	Limited third-party user reviews that map clearly to the product; public documentation gaps regarding some enterprise security features; integration complexity risk	Perceptions of complexity and cost; community feedback includes usability and availability concerns in some contexts	Mixed community feedback on usability versus alternatives; pricing not transparent

01Competitive Landscape

Narrative analysis

Areas where Miracle appears to align with buyer needs:

As an overlay dashboard, the product is positioned to provide visibility for teams that use multiple vendors and require consolidated operational reporting.
It may be a faster path to operational visibility than attempting to replace core systems mid-study.

Areas where competitors may have advantages:

Medidata and Veeva provide deeper end-to-end workflows (EDC, CTMS/eTMF, payments, etc.) and established enterprise governance.
Vendors focused on analytics or broader platforms (e.g., Saama) emphasize machine learning and automation at scale, which may be preferred by larger enterprises seeking advanced automation.

Sources: Official vendor product pages and broader industry coverage.

	Miracle (vendor product site)	Medidata (Rave / Clinical Cloud)	Veeva Vault EDC
Starting Price	Not publicly disclosed (tiered packaging only)	Not publicly disclosed; site-based pricing model described	Not publicly disclosed (contact sales)
Best For	Organizations seeking a dashboard/oversight layer that aggregates data across disparate systems	Sponsors/CROs seeking a broad, integrated clinical platform suite (EDC + adjacent modules)	Sponsors seeking an EDC integrated with Veeva’s broader clinical ecosystem
Key Strength	Positioned as an overlay dashboard providing visibility across disparate systems; focus on consolidating operational metrics and reporting	Mature enterprise platform breadth; widely used EDC ecosystem and integrations	Enterprise adoption and ecosystem integration with other Veeva products
Key Weakness	Limited third-party user reviews that map clearly to the product; public documentation gaps regarding some enterprise security features; integration complexity risk	Perceptions of complexity and cost; community feedback includes usability and availability concerns in some contexts	Mixed community feedback on usability versus alternatives; pricing not transparent

Miracle

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map